200 commonly prescribed drugs: generic and brand, class, the name stem that gives the class away, main use, the caution a technician flags to the pharmacist, storage and DEA schedule. Study it as a table or as flashcards.
This drug list has not yet been verified by a licensed pharmacist or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.
VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.
| # | Generic | Brand | Class | Use | Flag to pharmacist | Storage | DEA |
|---|---|---|---|---|---|---|---|
| 1 | atorvastatin -statin | Lipitor | HMG-CoA reductase inhibitor (statin) | hyperlipidemia, cardiovascular risk reduction | check for interacting drugs that raise statin levels (e.g., clarithromycin); counsel patient to report muscle pain LASA: pravastatin | room temperature | |
| 2 | levothyroxine | Synthroid | thyroid hormone | hypothyroidism | brand and generic are not automatically interchangeable; take on empty stomach 30–60 min before food LASA: liothyronine | room temperature, protect from light and moisture | |
| 3 | lisinopril -pril | Zestril | ACE inhibitor | hypertension, heart failure, post-MI | do not use in pregnancy; counsel patient to report persistent dry cough or swelling of face/tongue (angioedema) LASA: fosinopril | room temperature | |
| 4 | metformin | Glucophage | biguanide antidiabetic | type 2 diabetes | hold before iodinated contrast procedures; risk of lactic acidosis with renal impairment LASA: metronidazole | room temperature | |
| 5 | amlodipine -dipine | Norvasc | dihydropyridine calcium channel blocker | hypertension, angina | peripheral edema is common; grapefruit juice may increase drug levels LASA: amiloride | room temperature | |
| 6 | metoprolol succinate -olol | Toprol-XL | cardioselective beta-1 blocker | hypertension, heart failure, angina | do not abruptly discontinue; metoprolol succinate (ER) and metoprolol tartrate (IR) are NOT interchangeable dose-for-dose LASA: metoprolol tartrate | room temperature | |
| 7 | metoprolol tartrate -olol | Lopressor | cardioselective beta-1 blocker | hypertension, angina, post-MI | do not abruptly discontinue; IR formulation—not interchangeable with ER succinate salt LASA: metoprolol succinate | room temperature | |
| 8 | albuterol | ProAir HFA | short-acting beta-2 agonist (SABA) | bronchospasm, asthma rescue | shake inhaler before each use; prime new inhalers before first use; overuse may signal poorly controlled asthma LASA: Atrovent (ipratropium) | room temperature; store inhaler with mouthpiece down | |
| 9 | omeprazole -prazole | Prilosec | proton pump inhibitor (PPI) | GERD, peptic ulcer disease, H. pylori eradication | take 30–60 min before a meal; long-term use linked to magnesium deficiency and C. difficile risk LASA: esomeprazole | room temperature | |
| 10 | losartan -sartan | Cozaar | angiotensin II receptor blocker (ARB) | hypertension, diabetic nephropathy, stroke prevention in LVH | contraindicated in pregnancy; monitor potassium levels LASA: valsartan | room temperature | |
| 11 | gabapentin | Neurontin | anticonvulsant / neuropathic pain agent | neuropathic pain, partial seizures | causes sedation and dizziness; do not abruptly stop; some states have added scheduling LASA: pregabalin | room temperature | |
| 12 | hydrocodone/acetaminophen | Vicodin | opioid analgesic combination | moderate-to-severe pain | CII—requires written Rx; warn about acetaminophen dose limit (≤4 g/day total); risk of respiratory depression and dependence LASA: oxycodone/acetaminophen | room temperature | CII |
| 13 | sertraline | Zoloft | selective serotonin reuptake inhibitor (SSRI) | depression, anxiety disorders, OCD, PTSD | black box warning for suicidality in children/young adults; do not abruptly discontinue LASA: sertraline vs. cetirizine (sound-alike) | room temperature | |
| 14 | simvastatin -statin | Zocor | HMG-CoA reductase inhibitor (statin) | hyperlipidemia, cardiovascular risk reduction | 80 mg dose restricted due to myopathy risk; avoid grapefruit juice; many drug interactions LASA: atorvastatin | room temperature | |
| 15 | montelukast -lukast | Singulair | leukotriene receptor antagonist | asthma maintenance, allergic rhinitis | FDA boxed warning for neuropsychiatric events (mood changes, suicidal thinking); take in evening for asthma | room temperature, protect from moisture | |
| 16 | pantoprazole -prazole | Protonix | proton pump inhibitor (PPI) | GERD, erosive esophagitis, Zollinger-Ellison syndrome | swallow tablets whole; do not crush delayed-release tablets; long-term use linked to bone fracture risk LASA: omeprazole | room temperature | |
| 17 | amoxicillin | Amoxil | aminopenicillin antibiotic | bacterial infections (otitis media, sinusitis, pharyngitis, UTI) | ask about penicillin allergy before dispensing; complete full course LASA: amoxicillin/clavulanate | room temperature; reconstituted suspension: refrigeration preferred but not required, discard after 14 days | |
| 18 | furosemide | Lasix | loop diuretic | edema (heart failure, renal, hepatic), hypertension | monitor for electrolyte imbalances (hypokalemia); sulfonamide allergy cross-reactivity possible; take in morning to avoid nocturia LASA: torsemide | room temperature, protect from light | |
| 19 | fluticasone propionate nasal -asone | Flonase | intranasal corticosteroid | allergic rhinitis | prime before first use; direct spray away from nasal septum; effect may take days to weeks LASA: fluticasone furoate nasal | room temperature | |
| 20 | amlodipine/benazepril | Lotrel | calcium channel blocker / ACE inhibitor combination | hypertension | contraindicated in pregnancy; monitor for angioedema and cough (ACE inhibitor component) | room temperature | |
| 21 | azithromycin -thromycin | Zithromax | macrolide antibiotic | community-acquired pneumonia, skin infections, STIs | QT prolongation risk; drug interaction with other QT-prolonging agents; complete full course LASA: azathioprine | room temperature; reconstituted suspension also room temperature (do not refrigerate), discard after 10 days | |
| 22 | hydrochlorothiazide | Microzide | thiazide diuretic | hypertension, edema | monitor electrolytes (hypokalemia, hyponatremia); sulfonamide allergy; photosensitivity LASA: hydralazine | room temperature | |
| 23 | alprazolam -zolam | Xanax | benzodiazepine anxiolytic | anxiety disorders, panic disorder | CIV—requires valid Rx; risk of dependence, respiratory depression especially with opioids; do not abruptly stop LASA: lorazepam | room temperature | CIV |
| 24 | zolpidem | Ambien | non-benzodiazepine sedative-hypnotic (Z-drug) | insomnia | CIV; lower dose recommended for women and older adults; complex sleep behaviors possible; avoid alcohol LASA: zaleplon | room temperature | CIV |
| 25 | atorvastatin/amlodipine | Caduet | statin / calcium channel blocker combination | hypertension with hyperlipidemia | grapefruit juice interaction; report muscle pain; not for use in pregnancy | room temperature | |
| 26 | metformin/sitagliptin | Janumet | biguanide / DPP-4 inhibitor combination antidiabetic | type 2 diabetes | hold before iodinated contrast; risk of lactic acidosis; pancreatitis warning for sitagliptin component | room temperature | |
| 27 | clopidogrel -grel | Plavix | P2Y12 platelet aggregation inhibitor | prevention of thrombotic events (ACS, stroke, MI) | bleeding risk; CYP2C19 poor metabolizers have reduced efficacy; do not give with omeprazole if avoidable LASA: Pradaxa (dabigatran) — name confusion risk | room temperature | |
| 28 | prednisone | Deltasone | systemic corticosteroid | inflammation, autoimmune conditions, allergic reactions | do not abruptly stop after prolonged use (adrenal suppression); take with food; raises blood glucose LASA: prednisolone | room temperature | |
| 29 | esomeprazole -prazole | Nexium | proton pump inhibitor (PPI) | GERD, erosive esophagitis, H. pylori eradication | swallow capsules whole or open and sprinkle on applesauce; long-term use linked to magnesium and B12 deficiency LASA: omeprazole | room temperature | |
| 30 | tramadol | Ultram | opioid analgesic (mixed mechanism) | moderate-to-moderately severe pain | CIV; lowers seizure threshold; serotonin syndrome risk with SSRIs/SNRIs; abuse potential LASA: trazodone | room temperature | CIV |
| 31 | duloxetine | Cymbalta | serotonin-norepinephrine reuptake inhibitor (SNRI) | depression, anxiety, diabetic peripheral neuropathy, fibromyalgia | black box warning for suicidality; do not abruptly stop; do not crush or chew capsules LASA: fluoxetine | room temperature | |
| 32 | lisinopril/hydrochlorothiazide | Zestoretic | ACE inhibitor / thiazide diuretic combination | hypertension | contraindicated in pregnancy; monitor renal function and electrolytes; cough from ACE inhibitor component | room temperature | |
| 33 | warfarin | Coumadin | vitamin K antagonist anticoagulant | prevention/treatment of thromboembolic events, atrial fibrillation | narrow therapeutic index; many food (vitamin K) and drug interactions; regular INR monitoring required; bleeding risk LASA: Avandia (rosiglitazone) — name confusion | room temperature, protect from light | |
| 34 | carvedilol -olol | Coreg | non-selective beta blocker / alpha-1 blocker | heart failure, hypertension, post-MI | take with food to slow absorption and reduce orthostatic hypotension; do not abruptly discontinue LASA: carbamazepine | room temperature | |
| 35 | clonazepam -zepam | Klonopin | benzodiazepine | seizure disorders, panic disorder | CIV; dependence and withdrawal risk; CNS depression; avoid abrupt discontinuation LASA: clonidine | room temperature | CIV |
| 36 | rosuvastatin -statin | Crestor | HMG-CoA reductase inhibitor (statin) | hyperlipidemia, cardiovascular risk reduction | Asian patients may need lower starting doses; report muscle pain; avoid in pregnancy LASA: atorvastatin | room temperature | |
| 37 | cyclobenzaprine | Flexeril | skeletal muscle relaxant | acute musculoskeletal pain/spasm (short-term) | causes significant sedation and anticholinergic effects; avoid in elderly; avoid with MAOIs LASA: cyproheptadine | room temperature | |
| 38 | amoxicillin/clavulanate | Augmentin | aminopenicillin / beta-lactamase inhibitor antibiotic | bacterial infections (sinusitis, otitis media, skin, pneumonia) | check penicillin allergy; refrigerate reconstituted suspension; take with food to reduce GI upset LASA: amoxicillin | room temperature (tablets); refrigerate reconstituted suspension | |
| 39 | sitagliptin -gliptin | Januvia | DPP-4 inhibitor antidiabetic | type 2 diabetes | pancreatitis warning; dose adjustment required in renal impairment; watch for joint pain (arthralgia) LASA: saxagliptin | room temperature | |
| 40 | tamsulosin -osin | Flomax | alpha-1 adrenergic blocker (uroselective) | benign prostatic hyperplasia (BPH) | orthostatic hypotension, especially with first dose; swallow capsules whole; avoid with strong CYP3A4 inhibitors LASA: tamoxifen | room temperature | |
| 41 | fluoxetine | Prozac | selective serotonin reuptake inhibitor (SSRI) | depression, OCD, panic disorder, bulimia, PMDD | long half-life (active metabolite); black box warning for suicidality; serotonin syndrome risk; many drug interactions LASA: fluvoxamine | room temperature | |
| 42 | alendronate -dronate | Fosamax | bisphosphonate | osteoporosis, Paget's disease | take with full glass of water on empty stomach; remain upright 30 min after dose to prevent esophageal irritation LASA: risedronate | room temperature | |
| 43 | valsartan -sartan | Diovan | angiotensin II receptor blocker (ARB) | hypertension, heart failure, post-MI | contraindicated in pregnancy; monitor potassium and renal function LASA: losartan | room temperature | |
| 44 | citalopram | Celexa | selective serotonin reuptake inhibitor (SSRI) | depression | dose-dependent QT prolongation limits maximum daily dose; black box warning for suicidality LASA: escitalopram | room temperature | |
| 45 | escitalopram | Lexapro | selective serotonin reuptake inhibitor (SSRI) | depression, generalized anxiety disorder | black box warning for suicidality; do not abruptly stop; serotonin syndrome risk LASA: citalopram | room temperature | |
| 46 | oxycodone | OxyContin | opioid analgesic | moderate-to-severe pain | CII; abuse-deterrent formulations must not be crushed/chewed; high risk of respiratory depression and dependence LASA: oxycodone/acetaminophen | room temperature | CII |
| 47 | glipizide | Glucotrol | sulfonylurea antidiabetic | type 2 diabetes | hypoglycemia risk, especially if meal is missed; take 30 min before meal (IR); sulfonamide allergy cross-reactivity possible LASA: glyburide | room temperature | |
| 48 | pravastatin -statin | Pravachol | HMG-CoA reductase inhibitor (statin) | hyperlipidemia, cardiovascular risk reduction | fewer drug interactions than other statins (not metabolized by CYP3A4); report muscle pain LASA: atorvastatin | room temperature | |
| 49 | doxycycline -cycline | Vibramycin | tetracycline antibiotic | bacterial infections, acne, malaria prophylaxis, Lyme disease | photosensitivity—use sunscreen; avoid dairy and antacids within 2 hours; do not use in children under 8 or in pregnancy LASA: digoxin (name confusion in some settings) | room temperature, protect from light | |
| 50 | celecoxib -coxib | Celebrex | selective COX-2 inhibitor (NSAID) | osteoarthritis, rheumatoid arthritis, acute pain, ankylosing spondylitis | cardiovascular and GI risk (black box warning); avoid in patients with sulfonamide allergy; use lowest effective dose LASA: Celebrex vs. Celexa (citalopram) — well-known ISMP pair | room temperature | |
| 51 | bupropion | Wellbutrin | aminoketone antidepressant / smoking cessation aid | depression, smoking cessation | lowers seizure threshold; contraindicated in eating disorders and abrupt alcohol/benzodiazepine withdrawal LASA: buspirone | room temperature | |
| 52 | meloxicam -oxicam | Mobic | NSAID (preferential COX-2 inhibitor) | osteoarthritis, rheumatoid arthritis | cardiovascular and GI bleeding risk; avoid in late pregnancy | room temperature | |
| 53 | trazodone | serotonin antagonist and reuptake inhibitor (SARI) | depression, insomnia | priapism risk; advise patient to seek immediate care if prolonged erection occurs LASA: tramadol | room temperature | ||
| 54 | atenolol -olol | Tenormin | cardioselective beta-1 blocker | hypertension, angina | do not stop abruptly; may mask hypoglycemia signs in diabetics LASA: albuterol | room temperature | |
| 55 | clonidine | Catapres | central alpha-2 agonist / antihypertensive | hypertension, ADHD | do not stop abruptly; rebound hypertension possible LASA: clonazepam | room temperature | |
| 56 | glimepiride | Amaryl | sulfonylurea / antidiabetic | type 2 diabetes | hypoglycemia risk; advise patient not to skip meals LASA: glipizide | room temperature | |
| 57 | paroxetine -oxetine | Paxil | selective serotonin reuptake inhibitor (SSRI) | depression; anxiety disorders | Do not stop abruptly; flag MAOI or other serotonergic drugs to the pharmacist LASA: Paxil / Plavix / Taxol | room temperature | |
| 58 | famotidine | Pepcid | H2 receptor antagonist | GERD, peptic ulcer disease | dose adjustment required in renal impairment LASA: famciclovir | room temperature | |
| 59 | methylphenidate | Ritalin | CNS stimulant | ADHD, narcolepsy | high abuse potential; verify DEA schedule II prescription requirements LASA: methadone | room temperature | CII |
| 60 | amphetamine salts (mixed amphetamine salts) | Adderall | CNS stimulant | ADHD, narcolepsy | schedule II; no refills permitted; monitor for cardiovascular effects | room temperature | CII |
| 61 | insulin glargine | Lantus | long-acting insulin analog | type 1 and type 2 diabetes | do not mix with other insulins in the same syringe; refrigerate unopened vials LASA: insulin detemir | refrigerate unopened; opened vial or pen room temperature up to 28 days | |
| 62 | amlodipine/valsartan | Exforge | calcium channel blocker / ARB combination | hypertension | avoid in pregnancy (ARB component teratogenic) | room temperature | |
| 63 | spironolactone | Aldactone | potassium-sparing diuretic / aldosterone antagonist | heart failure, hypertension, edema | hyperkalemia risk; avoid high-potassium foods and potassium supplements | room temperature | |
| 64 | oxycodone/acetaminophen | Percocet | opioid analgesic combination | moderate to severe pain | schedule II; counsel on acetaminophen total daily dose limit (4 g/day); high abuse potential LASA: oxycodone | room temperature | CII |
| 65 | diltiazem | Cardizem | calcium channel blocker (non-dihydropyridine) | hypertension, angina, atrial fibrillation | do not crush or chew extended-release forms; multiple formulations with different release rates LASA: Cardene (nicardipine) | room temperature | |
| 66 | linagliptin -gliptin | Tradjenta | DPP-4 inhibitor / antidiabetic | type 2 diabetes | risk of pancreatitis; advise patient to report persistent abdominal pain | room temperature | |
| 67 | pregabalin | Lyrica | alpha-2-delta ligand / anticonvulsant | neuropathic pain, fibromyalgia, epilepsy | schedule V; dizziness and sedation; do not stop abruptly LASA: gabapentin | room temperature | CV |
| 68 | topiramate | Topamax | anticonvulsant | epilepsy, migraine prophylaxis | teratogenic (cleft palate); patients of childbearing age should use effective contraception LASA: Toprol XL (metoprolol succinate) | room temperature | |
| 69 | lamotrigine | Lamictal | anticonvulsant | epilepsy, bipolar disorder | risk of serious rash (Stevens-Johnson syndrome); dose escalation must be gradual LASA: labetalol | room temperature | |
| 70 | fluticasone/salmeterol | Advair | inhaled corticosteroid / long-acting beta-2 agonist (ICS/LABA) | asthma, COPD | LABA monotherapy contraindicated in asthma; rinse mouth after inhalation to prevent oral candidiasis | room temperature; store diskus in dry place | |
| 71 | venlafaxine | Effexor | serotonin-norepinephrine reuptake inhibitor (SNRI) | depression, anxiety disorders | do not stop abruptly; discontinuation syndrome common; monitor blood pressure (dose-related hypertension) LASA: Effexor vs. Effient confusion reported | room temperature | |
| 72 | metronidazole | Flagyl | nitroimidazole antibiotic/antiprotozoal | anaerobic infections, C. difficile, Trichomonas | disulfiram-like reaction with alcohol; advise patient to avoid alcohol during and 48 hours after therapy LASA: metformin | room temperature; protect from light | |
| 73 | allopurinol | Zyloprim | xanthine oxidase inhibitor / antigout agent | gout prophylaxis, hyperuricemia | do not initiate during acute gout attack; serious hypersensitivity reactions possible (especially with HLA-B*5801 allele in Asian patients) LASA: Zyrtec (cetirizine) | room temperature | |
| 74 | cetirizine | Zyrtec | second-generation antihistamine | allergic rhinitis, urticaria | may cause drowsiness; use caution when driving LASA: Zyprexa (olanzapine) | room temperature | |
| 75 | loratadine | Claritin | second-generation antihistamine | allergic rhinitis, urticaria | generally non-sedating; adjust dose in hepatic or renal impairment LASA: lorazepam | room temperature | |
| 76 | fexofenadine | Allegra | second-generation antihistamine | allergic rhinitis, chronic urticaria | avoid taking with fruit juices (grapefruit, orange, apple) — reduces absorption significantly | room temperature | |
| 77 | ondansetron -setron | Zofran | 5-HT3 antagonist / antiemetic | nausea and vomiting | QT prolongation risk; avoid in patients with congenital long QT syndrome LASA: Zosyn (piperacillin/tazobactam) | room temperature | |
| 78 | thyroid (desiccated) | Armour Thyroid | thyroid hormone (natural T4/T3) | hypothyroidism | Not interchangeable with levothyroxine dose-for-dose; flag any switch to the pharmacist | room temperature | |
| 79 | lisdexamfetamine | Vyvanse | CNS stimulant (prodrug of dextroamphetamine) | ADHD; binge-eating disorder | schedule II; no refills permitted; monitor heart rate and blood pressure | room temperature | CII |
| 80 | triamcinolone acetonide (nasal) | Nasacort | intranasal corticosteroid | allergic rhinitis | prime pump before first use; shake well; may take 1–2 weeks for full effect | room temperature | |
| 81 | mometasone furoate (nasal) | Nasonex | intranasal corticosteroid | allergic rhinitis, nasal polyps | prime and shake before use; onset may take several days | room temperature | |
| 82 | budesonide (nasal) | Rhinocort | intranasal corticosteroid | allergic rhinitis | available OTC; remind patients to prime before first use | room temperature | |
| 83 | tiotropium -tropium | Spiriva | long-acting anticholinergic bronchodilator (LAMA) | COPD maintenance | for inhalation only; do not swallow capsule; capsules must stay in blister pack until use | room temperature; protect from moisture | |
| 84 | ipratropium -tropium | Atrovent | short-acting anticholinergic bronchodilator | COPD, bronchospasm | avoid spraying in eyes; use caution in narrow-angle glaucoma LASA: Alupent (metaproterenol) | room temperature | |
| 85 | fluticasone (inhaled) | Flovent | inhaled corticosteroid | asthma maintenance | rinse mouth and gargle after each use to prevent oral candidiasis; not for acute bronchospasm | room temperature | |
| 86 | budesonide/formoterol | Symbicort | inhaled corticosteroid / LABA combination | asthma, COPD | rinse mouth after use; not for acute relief; LABA use requires ICS in asthma | room temperature | |
| 87 | dulaglutide -tide | Trulicity | GLP-1 receptor agonist / antidiabetic | type 2 diabetes | Weekly injection; GI effects; flag history of pancreatitis or thyroid C-cell tumors to the pharmacist | refrigerate; may be kept at room temperature up to 14 days | |
| 88 | fenofibrate -fibrate | TriCor | fibric acid derivative / antilipemic | hypertriglyceridemia, mixed dyslipidemia | myopathy risk increased when combined with statins; monitor renal function | room temperature | |
| 89 | ezetimibe | Zetia | cholesterol absorption inhibitor | hypercholesterolemia | often used with a statin; monitor LFTs if combined with statin LASA: Zestril (lisinopril) | room temperature | |
| 90 | tirzepatide -tide | Mounjaro | GIP/GLP-1 receptor agonist / antidiabetic | type 2 diabetes | Weekly injection; GI effects; flag history of pancreatitis or thyroid C-cell tumors to the pharmacist | refrigerate; may be kept at room temperature up to 21 days | |
| 91 | empagliflozin -gliflozin | Jardiance | SGLT2 inhibitor / antidiabetic | type 2 diabetes, heart failure, CKD | increased risk of urinary tract and genital yeast infections; counsel on genital hygiene | room temperature | |
| 92 | canagliflozin -gliflozin | Invokana | SGLT2 inhibitor / antidiabetic | type 2 diabetes, diabetic nephropathy | risk of lower-limb amputation and fractures; advise patient to inspect feet regularly | room temperature | |
| 93 | dapagliflozin -gliflozin | Farxiga | SGLT2 inhibitor / antidiabetic | type 2 diabetes, heart failure, CKD | hold before surgery; risk of diabetic ketoacidosis even with near-normal glucose | room temperature | |
| 94 | liraglutide -glutide | Victoza | GLP-1 receptor agonist / antidiabetic | type 2 diabetes, cardiovascular risk reduction | refrigerate until first use; after first use store at room temperature up to 30 days; risk of pancreatitis LASA: semaglutide | refrigerate until opened; then room temperature up to 30 days | |
| 95 | semaglutide -glutide | Ozempic | GLP-1 receptor agonist / antidiabetic | type 2 diabetes, cardiovascular risk reduction, weight management | refrigerate until first use; after opening use within 56 days; risk of thyroid C-cell tumors (black box warning) LASA: liraglutide | refrigerate until first use; after first use room temperature up to 56 days | |
| 96 | methotrexate | Trexall | antimetabolite / DMARD | rheumatoid arthritis, psoriasis, cancer | high-alert medication; weekly dosing for arthritis/psoriasis (daily dosing is a common fatal error); folic acid supplementation required LASA: methohexital | room temperature; protect from light | |
| 97 | hydroxychloroquine | Plaquenil | antimalarial / DMARD | rheumatoid arthritis, lupus, malaria | annual ophthalmologic exam required (retinal toxicity); take with food or milk LASA: hydrocortisone | room temperature; protect from light | |
| 98 | nitrofurantoin | Macrobid | nitrofuran antibiotic | uncomplicated urinary tract infection | take with food to reduce GI upset; avoid in patients with CrCl < 30 mL/min (ineffective and may accumulate) | room temperature; protect from light | |
| 99 | sulfamethoxazole/trimethoprim | Bactrim | sulfonamide / antibiotic combination | UTI, skin infections, Pneumocystis pneumonia prophylaxis | adequate hydration required; can cause severe hypersensitivity (Stevens-Johnson syndrome); monitor potassium (hyperkalemia risk) | room temperature | |
| 100 | amlodipine/olmesartan -sartan | Azor | calcium channel blocker / angiotensin II receptor blocker combination | hypertension | verify correct combination product; olmesartan associated with sprue-like enteropathy with long-term use LASA: Zocor | room temperature | |
| 101 | olmesartan -sartan | Benicar | angiotensin II receptor blocker | hypertension | may cause sprue-like enteropathy; counsel patients to report severe chronic diarrhea LASA: Mevacor | room temperature | |
| 102 | naproxen | Naprosyn | NSAID | pain, inflammation, arthritis | GI bleeding and kidney risk; flag anticoagulants, other NSAIDs and pregnancy to the pharmacist | room temperature | |
| 103 | quetiapine -apine | Seroquel | atypical antipsychotic | schizophrenia, bipolar disorder, adjunct for depression | black box warning: increased mortality in elderly patients with dementia-related psychosis LASA: Sinequan | room temperature | |
| 104 | aripiprazole -piprazole | Abilify | atypical antipsychotic | schizophrenia, bipolar disorder, adjunct for major depressive disorder | black box warning: increased mortality in elderly patients with dementia-related psychosis; monitor for impulse-control problems LASA: probenecid | room temperature | |
| 105 | risperidone -idone | Risperdal | atypical antipsychotic | schizophrenia, bipolar mania, irritability associated with autism | black box warning: increased mortality in elderly patients with dementia-related psychosis; monitor for extrapyramidal symptoms LASA: ropinirole | room temperature; oral solution protect from light | |
| 106 | olanzapine -apine | Zyprexa | atypical antipsychotic | schizophrenia, bipolar disorder | black box warning: increased mortality in elderly patients with dementia-related psychosis; significant weight gain and metabolic changes LASA: Zyrtec | room temperature | |
| 107 | clobetasol propionate | Temovate | topical corticosteroid (super-high potency) | inflammatory skin conditions, psoriasis | super-high potency; limit use to 2 weeks on face or intertriginous areas; adrenal suppression possible with overuse LASA: clotrimazole | room temperature | |
| 108 | amitriptyline -triptyline | Elavil | tricyclic antidepressant | depression, neuropathic pain, migraine prevention | anticholinergic effects; cardiotoxic in overdose; black box warning for suicidality in pediatric patients LASA: amoxapine | room temperature | |
| 109 | lorazepam -azepam | Ativan | benzodiazepine | anxiety, seizures, preoperative sedation | DEA Schedule IV; risk of dependence, abuse, and respiratory depression; avoid abrupt discontinuation LASA: alprazolam | room temperature; injectable form refrigerate | CIV |
| 110 | diazepam -azepam | Valium | benzodiazepine | anxiety, muscle spasms, alcohol withdrawal, seizures | DEA Schedule IV; risk of dependence and respiratory depression; long half-life increases accumulation risk in elderly LASA: Ditropan | room temperature; protect from light | CIV |
| 111 | morphine sulfate | MS Contin | opioid analgesic | moderate-to-severe pain | DEA Schedule II; high risk for misuse, addiction, respiratory depression; extended-release tablets must not be crushed LASA: hydromorphone | room temperature | CII |
| 112 | fentanyl transdermal -anyl | Duragesic | opioid analgesic | chronic severe pain requiring around-the-clock opioid | DEA Schedule II; patches contain large reservoir of drug; fatal if chewed, swallowed, or applied to cut skin; used patches still contain active drug LASA: fentanyl buccal film (separate product; do not interchange) | room temperature; used patches must be disposed of properly by folding adhesive side together | CII |
| 113 | methylprednisolone | Medrol | corticosteroid | inflammatory and allergic conditions | taper dose with prolonged use; adrenal suppression; Medrol Dosepak—counsel patient on the decreasing-dose regimen card LASA: medroxyprogesterone | room temperature | |
| 114 | triamterene/hydrochlorothiazide | Dyazide | potassium-sparing diuretic / thiazide diuretic combination | hypertension, edema | monitor potassium—triamterene component spares potassium while HCTZ wastes it; risk of hyperkalemia if combined with other K-sparing agents or ACE inhibitors LASA: triamcinolone | room temperature; protect from light | |
| 115 | amlodipine/valsartan/hydrochlorothiazide -sartan | Exforge HCT | calcium channel blocker / angiotensin II receptor blocker / thiazide diuretic combination | hypertension (add-on therapy) | verify all three components; contraindicated with aliskiren in diabetic patients; monitor electrolytes and renal function LASA: Exforge (two-drug combination) | room temperature | |
| 116 | potassium chloride | Klor-Con | electrolyte supplement | hypokalemia prevention and treatment | extended-release tablets must not be crushed; GI irritation common—take with food and full glass of water; IV form is a high-alert medication LASA: potassium phosphate | room temperature | |
| 117 | insulin aspart | NovoLog | rapid-acting insulin analog | diabetes mellitus (mealtime glucose control) | high-alert medication; administer within 5–10 minutes before a meal; refrigerate unopened vials/pens; discard open vials per manufacturer guidelines LASA: insulin lispro | refrigerate unopened; opened vials/pens room temperature up to 28 days | |
| 118 | insulin lispro | Humalog | rapid-acting insulin analog | diabetes mellitus (mealtime glucose control) | high-alert medication; administer within 15 minutes before or immediately after a meal; refrigerate unopened; LASA risk with other insulins LASA: insulin aspart | refrigerate unopened; opened vials/pens room temperature up to 28 days | |
| 119 | insulin NPH | Humulin N | intermediate-acting insulin | diabetes mellitus | high-alert medication; cloudy suspension—gently roll/invert to mix, do not shake; LASA risk with other insulin formulations LASA: Humulin R (regular insulin) | refrigerate unopened; opened vials room temperature up to 28–31 days per manufacturer | |
| 120 | insulin regular | Humulin R | short-acting insulin | diabetes mellitus, hyperkalemia (IV) | high-alert medication; only insulin formulation routinely used IV—verify concentration carefully; U-500 concentration available and must not be confused with U-100 LASA: insulin NPH (Humulin N) | refrigerate unopened; opened vials room temperature up to 28–31 days per manufacturer | |
| 121 | pioglitazone -glitazone | Actos | thiazolidinedione | type 2 diabetes mellitus | black box warning: may cause or exacerbate heart failure; associated with increased risk of bladder cancer with prolonged use LASA: Actonel | room temperature; protect from moisture and light | |
| 122 | metoclopramide | Reglan | dopamine antagonist / prokinetic | gastroparesis, GERD, nausea/vomiting | black box warning: irreversible tardive dyskinesia with long-term use; limit treatment to 12 weeks LASA: metolazone | room temperature | |
| 123 | olopatadine nasal -adine | Patanase | antihistamine (nasal) | allergic rhinitis | prime pump before first use and after periods of non-use; avoid spraying into eyes LASA: olopatadine ophthalmic (Pataday) | room temperature | |
| 124 | azelastine nasal -astine | Astelin | antihistamine (nasal) | allergic rhinitis, vasomotor rhinitis | may cause somnolence; instruct patient on proper nasal administration technique; prime pump LASA: Astepro (azelastine different concentration) | room temperature; upright position | |
| 125 | propranolol -olol | Inderal | beta-adrenergic blocker (non-selective) | hypertension, angina, migraine prevention, essential tremor, arrhythmias | do not abruptly discontinue—risk of rebound hypertension and angina; use with caution in asthma/COPD due to bronchospasm LASA: Pindolol | room temperature | |
| 126 | nebivolol -olol | Bystolic | beta-adrenergic blocker (selective beta-1) | hypertension | do not abruptly discontinue; use with caution in patients with severe hepatic impairment LASA: metoprolol | room temperature | |
| 127 | bisoprolol -olol | Zebeta | beta-adrenergic blocker (selective beta-1) | hypertension, heart failure | do not abruptly discontinue; cardioselective at low doses but selectivity decreases at higher doses LASA: metoprolol | room temperature | |
| 128 | amlodipine/telmisartan -sartan | Twynsta | calcium channel blocker / angiotensin II receptor blocker combination | hypertension | contraindicated in pregnancy; monitor renal function and electrolytes LASA: Micardis (telmisartan alone) | room temperature; protect from moisture | |
| 129 | telmisartan -sartan | Micardis | angiotensin II receptor blocker | hypertension, cardiovascular risk reduction | contraindicated in pregnancy; avoid concomitant use with ACE inhibitors in patients with diabetes or renal impairment LASA: olmesartan | room temperature; store in original blister packaging | |
| 130 | irbesartan -sartan | Avapro | angiotensin II receptor blocker | hypertension, diabetic nephropathy | contraindicated in pregnancy; monitor renal function and potassium LASA: valsartan | room temperature | |
| 131 | nifedipine -dipine | Procardia XL | dihydropyridine calcium channel blocker | hypertension, angina | extended-release tablet shell may appear in stool—counsel patient this is normal and does not mean the medication is not working LASA: nicardipine | room temperature; protect from light and moisture | |
| 132 | isosorbide mononitrate | Imdur | nitrate | angina prophylaxis | requires nitrate-free interval (10–14 hours) to prevent tolerance; do not crush extended-release tablets; can cause severe hypotension with PDE-5 inhibitors LASA: isosorbide dinitrate | room temperature; protect from moisture | |
| 133 | nitroglycerin sublingual | Nitrostat | nitrate | acute angina | store in original glass bottle away from heat and light; replace 6 months after opening bottle; counsel patient on proper sublingual administration and when to call 911 LASA: nitrofurantoin | room temperature; original glass amber bottle; protect from heat and light | |
| 134 | digoxin | Lanoxin | cardiac glycoside | heart failure, atrial fibrillation | narrow therapeutic index; toxicity signs include nausea, visual changes (yellow-green halos), and bradycardia; monitor serum levels and renal function LASA: Desoxyn | room temperature; protect from light | |
| 135 | amiodarone | Cordarone | antiarrhythmic (class III) | ventricular arrhythmias, atrial fibrillation | numerous serious adverse effects including pulmonary toxicity, thyroid dysfunction, and hepatotoxicity; multiple significant drug interactions; extremely long half-life LASA: amrinone (inamrinone) | room temperature; protect from light | |
| 136 | apixaban -xaban | Eliquis | direct oral anticoagulant (factor Xa inhibitor) | stroke prevention in atrial fibrillation, DVT/PE treatment and prevention | no routine antidote widely available (andexanet alfa exists but limited availability); counsel patient never to stop without physician guidance; interacts with strong CYP3A4/P-gp inhibitors LASA: Arixtra (fondaparinux) | room temperature | |
| 137 | rivaroxaban -xaban | Xarelto | direct oral anticoagulant (factor Xa inhibitor) | stroke prevention in atrial fibrillation, DVT/PE treatment and prevention | take with evening meal for AFib indication; no routine monitoring but interacts with CYP3A4/P-gp inhibitors and inducers; no reversal agent universally available LASA: Pradaxa (dabigatran) | room temperature | |
| 138 | dabigatran -gatran | Pradaxa | direct oral anticoagulant (direct thrombin inhibitor) | stroke prevention in atrial fibrillation, DVT/PE treatment and prevention | store capsules in original bottle—moisture-sensitive; discard 4 months after opening bottle; reversal agent idarucizumab (Praxbind) available; avoid crushing LASA: rivaroxaban | room temperature; original bottle; discard 4 months after opening | |
| 139 | ibuprofen -profen | Motrin | NSAID | pain, fever, inflammation | GI bleeding and kidney risk; flag anticoagulants and other NSAIDs to the pharmacist | room temperature | |
| 140 | simvastatin/ezetimibe -statin | Vytorin | HMG-CoA reductase inhibitor / cholesterol absorption inhibitor combination | hyperlipidemia | simvastatin 80 mg dose restricted due to myopathy risk; avoid grapefruit juice; multiple drug interactions with simvastatin component LASA: Liptruzet | room temperature | |
| 141 | colchicine | Colcrys | antigout agent | acute gout flares, gout prophylaxis, familial Mediterranean fever | narrow therapeutic index; toxicity (GI, myopathy) possible; significant interactions with CYP3A4/P-gp inhibitors (e.g., clarithromycin) LASA: Cortef (hydrocortisone) | room temperature; protect from light | |
| 142 | febuxostat | Uloric | xanthine oxidase inhibitor | chronic gout (hyperuricemia) | black box warning: cardiovascular death risk; use only in patients unresponsive to or intolerant of allopurinol; do not use during acute gout flare LASA: allopurinol | room temperature; protect from light | |
| 143 | fluconazole -conazole | Diflucan | triazole antifungal | candidiasis, cryptococcal meningitis, tinea infections | significant drug interactions via CYP2C9 and CYP3A4 inhibition; single-dose 150 mg for vaginal candidiasis—counsel patient LASA: Flagyl (metronidazole) | room temperature; oral suspension refrigerate or room temperature up to 2 weeks | |
| 144 | levofloxacin -floxacin | Levaquin | fluoroquinolone antibiotic | respiratory, urinary tract, and skin infections | black box warning: tendinitis/tendon rupture, peripheral neuropathy, CNS effects, and aortic aneurysm; avoid in patients with history of tendon problems; take with full glass of water LASA: levothyroxine | room temperature | |
| 145 | ciprofloxacin -floxacin | Cipro | fluoroquinolone antibiotic | broad-spectrum bacterial infections including UTI, respiratory, skin | black box warning: tendinitis/tendon rupture, peripheral neuropathy, CNS effects; separate from antacids, calcium, iron, and zinc by 2 hours; interacts with theophylline and warfarin LASA: cephalexin | room temperature; reconstituted suspension refrigerated or at room temperature, discard after 14 days | |
| 146 | cephalexin cef- | Keflex | first-generation cephalosporin antibiotic | skin, soft tissue, respiratory, and urinary tract infections | use with caution in penicillin-allergic patients (cross-reactivity rare but possible); take with or without food LASA: cefadroxil | room temperature; oral suspension refrigerate; discard after 14 days | |
| 147 | clindamycin | Cleocin | lincosamide antibiotic | skin, soft tissue, bone infections; bacterial vaginosis; dental prophylaxis | risk of Clostridioides difficile-associated diarrhea; counsel patients to report severe diarrhea; topical forms available for acne and BV LASA: clarithromycin | room temperature; reconstituted oral solution at room temperature (do not refrigerate — it thickens), discard after 14 days | |
| 148 | mupirocin | Bactroban | topical antibiotic | impetigo, nasal decolonization of MRSA | for external use only; nasal and topical formulations are different products and not interchangeable; not for ophthalmic use LASA: bacitracin | room temperature | |
| 149 | benzonatate | Tessalon | non-opioid antitussive | symptomatic relief of cough | capsules must be swallowed whole—do not chew or crush; numbing of oropharynx can cause choking and aspiration; keep out of reach of children LASA: benztropine | room temperature | |
| 150 | promethazine | Phenergan | phenothiazine antihistamine / antiemetic | nausea/vomiting, motion sickness, allergic conditions, sedation | black box warning: respiratory depression in children under 2 years—contraindicated; IV injection associated with severe tissue injury; prefer oral or rectal route in outpatient setting LASA: chlorpromazine | room temperature; protect from light | |
| 151 | hydralazine | Apresoline | direct-acting vasodilator | hypertension, heart failure | monitor for lupus-like syndrome with prolonged use; flag to pharmacist LASA: hydroxyzine | room temperature | |
| 152 | hydroxyzine | Vistaril | antihistamine / anxiolytic | anxiety, pruritus, nausea | causes sedation; counsel patient not to drive LASA: hydralazine | room temperature | |
| 153 | buspirone | Buspar | anxiolytic (azapirone) | generalized anxiety disorder | not effective for acute anxiety; takes weeks for full effect LASA: bupropion | room temperature | |
| 154 | mirtazapine | Remeron | antidepressant (NaSSA) | depression | causes significant sedation and weight gain; counsel patient LASA: metronidazole | room temperature | |
| 155 | nortriptyline | Pamelor | tricyclic antidepressant | depression, neuropathic pain | anticholinergic effects; risk of QT prolongation; avoid abrupt discontinuation LASA: amitriptyline | room temperature | |
| 156 | doxazosin -zosin | Cardura | alpha-1 blocker | hypertension, benign prostatic hyperplasia | first-dose orthostatic hypotension; advise patient to rise slowly LASA: doxepin | room temperature | |
| 157 | terazosin -zosin | Hytrin | alpha-1 blocker | hypertension, benign prostatic hyperplasia | first-dose orthostatic hypotension; take first dose at bedtime LASA: temazepam | room temperature | |
| 158 | finasteride -asteride | Proscar | 5-alpha reductase inhibitor | benign prostatic hyperplasia, male pattern baldness | women who are or may be pregnant must not handle crushed tablets; teratogenic LASA: furosemide | room temperature | |
| 159 | dutasteride -asteride | Avodart | 5-alpha reductase inhibitor | benign prostatic hyperplasia | pregnancy exposure risk; do not donate blood for 6 months after use LASA: finasteride | room temperature | |
| 160 | sildenafil -afil | Viagra | PDE-5 inhibitor | erectile dysfunction, pulmonary arterial hypertension | absolutely contraindicated with nitrates; can cause severe hypotension LASA: silodosin | room temperature | |
| 161 | tadalafil -afil | Cialis | PDE-5 inhibitor | erectile dysfunction, benign prostatic hyperplasia, pulmonary arterial hypertension | contraindicated with nitrates; counsel on 36-hour duration of action LASA: sildenafil | room temperature | |
| 162 | testosterone (topical/transdermal) | AndroGel | androgen | hypogonadism (males) | secondary exposure risk to women and children via skin contact; wash hands after application | room temperature; flammable gel | CIII |
| 163 | levonorgestrel/ethinyl estradiol | Seasonique | combination oral contraceptive | contraception | increased risk of VTE; contraindicated in smokers over 35 years old | room temperature | |
| 164 | norethindrone | Camila | progestin-only oral contraceptive | contraception | must be taken at the same time each day; no estrogen-related VTE concern | room temperature | |
| 165 | medroxyprogesterone acetate | Depo-Provera | progestin | contraception, abnormal uterine bleeding, endometriosis | prolonged use associated with bone density loss; counsel on return of fertility delay LASA: methylprednisolone | room temperature (injectable); refrigerate if specified on label | |
| 166 | estradiol (oral/transdermal) | Estrace | estrogen | menopausal symptoms, hormone replacement therapy | increased risk of VTE, stroke, and breast cancer with prolonged use; counsel patient | room temperature | |
| 167 | conjugated estrogens | Premarin | estrogen | menopausal symptoms, hormone replacement therapy, osteoporosis prevention | Black Box Warning for cardiovascular events and malignancy; use lowest effective dose | room temperature | |
| 168 | calcitonin (salmon) | Miacalcin | bone resorption inhibitor (calcitonin) | osteoporosis (postmenopausal), Paget's disease, hypercalcemia | nasal spray: alternate nostrils daily; injectable: risk of hypersensitivity | unopened: refrigerate; opened nasal spray: room temperature up to 35 days | |
| 169 | risedronate -dronate | Actonel | bisphosphonate | osteoporosis, Paget's disease | take with full glass of water, remain upright 30 minutes; risk of esophageal irritation LASA: alendronate | room temperature | |
| 170 | denosumab -mab | Prolia | RANK ligand inhibitor (monoclonal antibody) | osteoporosis, bone loss prevention | refrigerate; do not freeze; given by healthcare professional every 6 months | refrigerate; do not freeze | |
| 171 | calcium carbonate | Tums | antacid / calcium supplement | heartburn, calcium supplementation, hyperphosphatemia | take with food for best calcium absorption; interacts with many drugs (spacing required) LASA: calcium acetate | room temperature | |
| 172 | cholecalciferol (vitamin D3) | vitamin / fat-soluble vitamin | vitamin D deficiency, osteoporosis prevention | high doses can cause hypercalcemia; advise patient not to take excessive amounts LASA: ergocalciferol | room temperature; protect from light | ||
| 173 | folic acid | water-soluble vitamin / hematopoietic agent | folate deficiency, prevention of neural tube defects | high doses may mask vitamin B12 deficiency anemia; assess B12 status LASA: folinic acid (leucovorin) | room temperature; protect from light | ||
| 174 | cyanocobalamin (vitamin B12) | water-soluble vitamin | vitamin B12 deficiency, pernicious anemia | intranasal or injectable route required if GI absorption is impaired (pernicious anemia) | room temperature; protect from light | ||
| 175 | ferrous sulfate | Feosol | iron supplement | iron deficiency anemia | stools will appear dark or black; take on empty stomach if tolerated; keep away from children (iron poisoning risk) LASA: ferrous gluconate | room temperature | |
| 176 | polyethylene glycol 3350 | MiraLax | osmotic laxative | constipation | do not use more than 7 days without physician guidance; ensure adequate fluid intake | room temperature | |
| 177 | lactulose | Enulose | osmotic laxative / ammonia detoxicant | constipation, hepatic encephalopathy | may cause flatulence and cramping; dose titrated to produce 2-3 soft stools per day for encephalopathy | room temperature; do not freeze | |
| 178 | docusate sodium | Colace | stool softener | constipation prevention | does not stimulate bowel movement; adequate fluid intake enhances effect LASA: docusate calcium | room temperature | |
| 179 | senna | Senokot | stimulant laxative | constipation, opioid-induced constipation | may cause abdominal cramping; prolonged use not recommended without medical supervision | room temperature | |
| 180 | loperamide | Imodium | antidiarrheal (opioid receptor agonist - peripheral) | diarrhea | do not use in infectious diarrhea with fever or blood in stool; high doses associated with cardiac arrhythmia | room temperature | |
| 181 | dicyclomine | Bentyl | anticholinergic / antispasmodic | irritable bowel syndrome | anticholinergic side effects (dry mouth, urinary retention, constipation); avoid in elderly LASA: doxycycline | room temperature | |
| 182 | sulfasalazine | Azulfidine | aminosalicylate / DMARD | ulcerative colitis, rheumatoid arthritis | sulfa allergy contraindication; monitor CBC and LFTs; take with food and plenty of water | room temperature | |
| 183 | mesalamine | Asacol HD | aminosalicylate | ulcerative colitis, Crohn's disease | do not crush or chew delayed-release tablets; renal monitoring recommended | room temperature | |
| 184 | lansoprazole -prazole | Prevacid | proton pump inhibitor | GERD, peptic ulcer disease, H. pylori eradication | take 30-60 minutes before a meal for best effect; long-term use may decrease magnesium and B12 LASA: dexlansoprazole | room temperature | |
| 185 | dexlansoprazole -prazole | Dexilant | proton pump inhibitor | GERD, erosive esophagitis | capsule may be opened and sprinkled on food; do not crush granules LASA: lansoprazole | room temperature | |
| 186 | sucralfate | Carafate | mucosal protectant | duodenal ulcer, stress ulcer prophylaxis | take on empty stomach 1 hour before meals; separates many drugs (give other meds 2 hours apart) | room temperature | |
| 187 | acyclovir -vir | Zovirax | antiviral (nucleoside analog) | herpes simplex, herpes zoster (shingles), varicella | adequate hydration required; adjust dose in renal impairment LASA: valacyclovir | room temperature | |
| 188 | valacyclovir -vir | Valtrex | antiviral (prodrug of acyclovir) | herpes simplex, herpes zoster, genital herpes suppression | ensure adequate fluid intake; dose adjustment needed for renal impairment LASA: acyclovir | room temperature | |
| 189 | oseltamivir -vir | Tamiflu | antiviral (neuraminidase inhibitor) | influenza treatment and prophylaxis | most effective when started within 48 hours of symptom onset; oral suspension requires refrigeration | capsules: room temperature; reconstituted suspension: refrigerate | |
| 190 | latanoprost ophthalmic -prost | Xalatan | prostaglandin analog (ophthalmic) | glaucoma; ocular hypertension | Can darken iris color; remove contact lenses before use | refrigerate unopened bottles; after opening room temperature up to 6 weeks | |
| 191 | nystatin | Mycostatin | polyene antifungal | oral and mucocutaneous candidiasis | swish and swallow for oral thrush; not absorbed systemically when given orally | room temperature; refrigerate suspension if specified | |
| 192 | baclofen | Lioresal | skeletal muscle relaxant (GABA-B agonist) | spasticity (multiple sclerosis, spinal cord injury) | do not abruptly discontinue (risk of seizures, hallucinations); causes CNS depression | room temperature | |
| 193 | tizanidine | Zanaflex | central alpha-2 agonist / muscle relaxant | muscle spasticity | significant first-pass variability; tablets and capsules are NOT interchangeable dose-for-dose on empty vs. full stomach LASA: tiZANidine vs. tiagaBINE (ISMP) | room temperature | |
| 194 | carbamazepine | Tegretol | anticonvulsant / mood stabilizer | epilepsy, trigeminal neuralgia, bipolar disorder | many drug interactions (potent CYP inducer); autoinduction of its own metabolism; monitor CBC LASA: oxcarbazepine | room temperature; store away from humidity | |
| 195 | oxcarbazepine | Trileptal | anticonvulsant | epilepsy (partial seizures) | monitor sodium levels (risk of hyponatremia); cross-hypersensitivity with carbamazepine possible LASA: carbamazepine | room temperature | |
| 196 | levetiracetam -acetam | Keppra | anticonvulsant | epilepsy (various seizure types) | behavioral/psychiatric side effects (irritability, aggression); dose adjust in renal impairment LASA: levofloxacin | room temperature | |
| 197 | lithium carbonate | Lithobid | mood stabilizer | bipolar disorder | narrow therapeutic index; toxicity risk with dehydration, NSAIDs, or diuretics; regular serum level monitoring required | room temperature | |
| 198 | memantine | Namenda | NMDA receptor antagonist | moderate-to-severe Alzheimer's disease | dose titration required; use caution in severe renal impairment | room temperature | |
| 199 | donepezil | Aricept | acetylcholinesterase inhibitor | Alzheimer's disease (all stages) | take at bedtime to reduce GI side effects; may cause vivid dreams or insomnia if taken in morning | room temperature | |
| 200 | sumatriptan -triptan | Imitrex | triptan (selective serotonin 5-HT1B/1D agonist) | acute migraine, cluster headache | contraindicated in ischemic heart disease, uncontrolled hypertension, or within 24 hours of ergotamine; not for migraine prevention LASA: zolmitriptan | room temperature; protect from light |
A free tech program — complimentary, as our commitment to get America working. Help us build VoTechWorks. Tell us what works, what doesn’t, and what you want to learn.